The U.S. FDA has approved the use of tebipenem pivoxil (Utebzi), an oral carbapenem, for complicated urinary tract infection (UTI), including pyelonephritis. "This approval comes as bittersweet news to those of us who value timely treatment of ESBL-associated UTI but also worry about the consequences of increased carbapenem use👆👆
1August 10, 2026 1.5K